SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-027011
Filing Date
2021-07-01
Accepted
2021-07-01 19:00:35
Documents
1
Period of Report
2021-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 21000
  Complete submission text file 0000899243-21-027011.txt   22546
Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Lehrer-Graiwer Joshua (Reporting) CIK: 0001789673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 211067523

Mailing Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080
Business Address 279 EAST GRAND AVENUE, SUITE 430 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Issuer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences